Current Research:

The Magaña Lab bridges the clinic and the laboratory by utilizing a multidisciplinary and innovative approach to advancing the field of pediatric neuroimmunology. Dr. Magaña’s clinical and research focus is on studying the age-span of multiple sclerosis—fetal and neonatal neurology, as well as childhood, adolescent and adult neurology. Specifically, Dr. Magaña is interested in understanding how endogenous nanoparticles shed from all cells, called extracellular vesicles (EVs), mediate cross-talk between cells of the nervous and immune systems.

The overall goal of our interdisciplinary laboratory is to be at the forefront of innovative translational neuroimmunology research by focusing on three main aspects of multiple sclerosis research:

1. Elucidating pathomechanisms at the earliest phases of disease initiation
2. Developing novel human-based pre-clinical models
3. Identifying therapeutic candidates for precision nanomedicine